Astronics (ATRO) Q2 2023: Backlog Hits $611M as Aerospace Recovery Drives Multi-Year Highs
Record backlog and pre-pandemic order levels signal Astronics’ aerospace recovery is gaining traction, with operational momentum despite persistent supply chain and legal cost headwinds. Management’s focus on margin recapture and new program ramp sets the stage for long-term earnings leverage, but cash flow and inventory discipline remain critical watchpoints into year end.
Summary
- Backlog Expansion: Scheduled backlog reached $611M, underpinned by strong aerospace demand and new program wins.
- Margin Leverage Efforts: Supply chain stabilization and contract repricing are expected to drive further margin recovery.
- Execution Watchpoint: Cash flow and inventory management are crucial as working capital remains elevated.
Business Overview
Astronics Corporation designs and manufactures advanced technologies for the aerospace, defense, and electronics markets. The company’s core revenue streams come from its Aerospace segment, which provides power, lighting, and connectivity solutions to commercial and business aviation OEMs (original equipment manufacturers) and airlines, and its Test Systems segment, which delivers test solutions for military and commercial electronics. Aerospace accounted for over 90% of Q2 sales, with Test comprising the balance.
Performance Analysis
Astronics delivered its strongest quarter since early 2020, with sales up 35% year-over-year and sequential growth of 11%, propelled by continued aerospace recovery. The Aerospace segment drove the performance, posting a 45% YoY increase, while the Test segment lagged, down 19% YoY, reflecting program timing and cost structure misalignment. Adjusted EBITDA improved sharply to $15.8M (9.1% margin), marking a meaningful turnaround from the prior year’s near break-even level, as higher volumes and improved supply chain reliability translated into better operating leverage.
Despite this operational progress, net loss persisted, driven by elevated legal expenses and an unusual tax charge linked to deferred tax asset accounting. Working capital needs remained high, with inventory and receivables both increasing due to late-quarter shipments and supply chain inefficiencies. However, management expects inventory to have peaked, forecasting a reduction in the second half as backlog converts to shipments and supply chain pressures ease. Bookings of $207M set a pre-pandemic pace, and the company ended the quarter with a record $611M backlog, of which $330M is scheduled for shipment in the second half of 2023.
- Aerospace Outperformance: Aerospace revenue growth outpaced overall company growth, now representing the vast majority of sales and driving margin expansion.
- Test Segment Drag: Test Systems continues to underperform, with cost structure and program delays weighing on segment profitability.
- Legal and Tax Overhang: Elevated legal costs and non-cash tax charges distorted net income, masking underlying EBITDA progress.
Overall, the quarter marked a clear inflection in operational momentum, but the company’s full financial recovery hinges on sustained execution in margin management, working capital discipline, and program ramp-up in both core segments.
Executive Commentary
"We think our second quarter was a pretty strong step forward for our company, easily the best quarter we've had since COVID took over in early 2020. Volume continues to ramp. We're recovering our production rates, and that has a lot to do with our supply chain, which is getting quite a bit better as time goes on. The third prominent theme is that demand for our products remains very strong."
Peter Gunderman, Chairman, President, and CEO
"Our operating income for the quarter was $2.4 million, which was our first positive operating income since 2019, and a $4.8 million improvement compared with our first quarter of this year. Driving the margin improvement was a 47 percent contribution margin on the incremental aerospace sales as compared with the sequential first quarter."
Dave Burney, Chief Financial Officer
Strategic Positioning
1. Aerospace Demand and Program Wins
Resurgent aerospace demand is the core driver of Astronics’ recovery, with bookings and backlog now at or above pre-pandemic levels. New program wins, including the Airbus A220 PSU and next-gen in-seat power for Southwest, are not yet fully reflected in revenue but represent future growth catalysts as they ramp into production in late 2024 and beyond.
2. Supply Chain Stabilization
Supply chain improvements are enabling higher production rates and reduced reliance on costly spot buys, which historically weighed on margins. While not fully normalized, management expects further reduction in lead times and input costs, supporting ongoing margin recapture as new contracts incorporate inflation-adjusted pricing.
3. Test Systems Turnaround Potential
The Test segment remains a drag on consolidated profitability, but management is targeting a turnaround via restructuring and anticipated contract wins, notably the U.S. Army’s 4549T radio test platform. Execution on these programs is critical for restoring segment margins and reducing stranded costs.
4. Legal Expense and Risk Management
Ongoing legal disputes, primarily related to in-seat power IP litigation, have resulted in significant expenses and reserve accruals. Management expects some cases to resolve by 2024–2025, which could eliminate a major drag on profitability, but timing remains uncertain and legal costs may persist in the near term.
5. Working Capital and Cash Flow Discipline
Elevated inventory and receivables have constrained liquidity, but management is forecasting positive cash flow for the remainder of the year as backlog converts and inventory normalizes. Sustained improvement here is essential for supporting growth and maintaining debt covenant compliance.
Key Considerations
The quarter’s results highlight Astronics’ ability to capitalize on aerospace recovery, but also underscore the operational complexity and execution risk inherent in a multi-segment industrial business.
Key Considerations:
- Backlog Conversion Pace: Timely conversion of the $330M scheduled backlog is critical for meeting guidance and supporting cash flow.
- Margin Recapture Trajectory: Success in passing through input cost inflation and reducing spot buys will determine the durability of margin improvement.
- Test Segment Execution: The ability to secure and ramp new defense contracts is vital for restoring profitability in the Test business.
- Legal Cost Uncertainty: Ongoing litigation remains a wildcard, with potential to swing future earnings in either direction depending on outcomes and timing.
- Inventory and Receivables Management: Working capital normalization will be a key determinant of near-term liquidity and financial flexibility.
Risks
Persistent supply chain disruptions, especially in electronics, continue to pose fulfillment risk and could delay backlog conversion. Legal liabilities and associated costs from ongoing IP litigation represent a material earnings overhang through at least 2024. Test Systems underperformance may persist if contract awards are delayed or if restructuring fails to realign costs. Working capital pressure could constrain liquidity if inventory and receivables do not normalize as forecast.
Forward Outlook
For Q3 2023, Astronics expects revenue to be roughly in line with Q2, with some upside or downside variability. For full-year 2023, management maintained revenue guidance of $640M to $680M, focusing on the high end as a directional target.
- Q3 revenue expected to be similar to Q2
- Full-year 2023 revenue guidance held at $640M–$680M
Management highlighted several factors that will shape execution:
- Backlog conversion and incremental “pop-up” orders are needed to reach the high end of guidance.
- Margin improvement is expected from lower spot buys and successful contract repricing, but full normalization will be a multi-quarter process.
Takeaways
Astronics’ Q2 marks a clear operational inflection, but the path to sustained profitability depends on execution in backlog conversion, margin recapture, and segment turnaround.
- Aerospace Recovery Is Driving Growth: Bookings and backlog at multi-year highs set a solid foundation for future revenue, with new program wins providing additional upside.
- Margin and Cash Flow Remain Key Levers: Operational leverage is returning, but legal costs and working capital must be managed tightly to support earnings quality and liquidity.
- Execution on Test Programs and Legal Resolution Will Be Critical: Investors should watch for progress on defense contract awards and litigation outcomes as major catalysts for both risk reduction and earnings upside.
Conclusion
Astronics’ Q2 2023 results confirm the company’s aerospace-led recovery is on track, with record backlog and improved margins signaling a return to pre-pandemic form. Execution risk remains, particularly around working capital and legal costs, but the strategic foundation for long-term growth is strengthening.
Industry Read-Through
Astronics’ results reinforce a broad-based recovery in commercial aerospace, with OEM and airline demand for cabin upgrades, power systems, and connectivity solutions rebounding toward pre-pandemic levels. Supply chain normalization is slowly unlocking production across the sector, though persistent electronics shortages and long lead times remain a challenge for all suppliers. Defense electronics and test program delays are not unique to Astronics, highlighting ongoing complexity in government procurement and the need for operational agility. Legal risk from IP disputes is a sector-wide concern, especially as competition intensifies in high-value avionics and cabin systems. Investors should expect continued margin and cash flow volatility across the aerospace supply chain as the recovery matures.